Dimethylfumarate Is a Potent Inducer of Apoptosis in Human T Cells
Top Cited Papers
Open Access
- 1 December 2003
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 121 (6), 1383-1388
- https://doi.org/10.1111/j.1523-1747.2003.12605.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- T cell selective apoptosis by a novel immunosuppressant, FTY720, is closely regulated with Bcl‐2British Journal of Pharmacology, 2002
- Dominant Lesional T Cell Receptor Rearrangements Persist in Relapsing Psoriasis but are Absent from Nonlesional Skin: Evidence for a Stable Antigen-Specific Pathogenic T Cell Response in Psoriasis VulgarisJournal of Investigative Dermatology, 2001
- Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic useBritish Journal of Dermatology, 1999
- Dendritic Cell Survival and Maturation Are Regulated by Different Signaling PathwaysThe Journal of Experimental Medicine, 1998
- Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells.Journal of Clinical Investigation, 1998
- Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre studyBritish Journal of Dermatology, 1998
- Dimethylfumarate Is an Inhibitor of Cytokine-Induced E-Selectin, VCAM-1, and ICAM-1 Expression in Human Endothelial CellsBiochemical and Biophysical Research Communications, 1997
- Antipsoriatic effect of fumaric acid derivativesJournal of the American Academy of Dermatology, 1994
- CD4 antibody treatment of severe psoriasisThe Lancet, 1991
- Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasisThe Lancet, 1991